Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

KALVKALV
Showing 8 of 29 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in KALVISTA PHARMACEUTICALS INC

BNP PARIBAS FINANCIAL MARKETS previously held 0 shares of KALV (KALVISTA PHARMACEUTICALS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$501,368

Total Shares Change

-43,296

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$27.00
0
2026-Q1
Increased
11,974
+192.8%
$241,0370.0%$15.61
37
2025-Q4
Decreased
4,090
-47.5%
$66,0540.0%$15.68
0
2025-Q3
Increased
7,794
+92.9%
$94,9310.0%$12.21
34
2025-Q2
Increased
4,041
+47.0%
$45,6830.0%$11.41
19
2025-Q1
Decreased
2,749
-56.0%
$31,7230.0%$11.93
0
2024-Q4
Decreased
6,252
-85.6%
$52,9540.0%$8.39
0
2024-Q3
Increased
43,296
+1335.5%
$501,3680.0%$12.34
39

Other major holders of KALV: BlackRock, Inc., Capital World Investors, MILLENNIUM MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used